Evidence map›Paper›PMID 21450902›Full record

ArticleBlood2011

Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.

Helen He Zhu, Kaihong Ji, Nazilla Alderson, Zhao He, Shuangwei Li, Wen Liu, Dong-Er Zhang, Linheng Li, Gen-Sheng Feng

Abstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Complex Roles ofAnnual review of cancer biology · 2024
    Article
  7. From Stem to Sternum: The Role of Shp2 in the Skeleton.Calcified tissue international · 2023
    Review
  8. Article
  9. Strategy for Leukemia Treatment Targeting SHP-1,2 and SHIP.Frontiers in cell and developmental biology · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. SteamedFrontiers in pharmacology · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Helen He ZhuDepartment of Pathology, School of Medicine, and Section of Molecular Biology, Division of Biological Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Kaihong Ji
Nazilla Alderson
Zhao He
Shuangwei Li
Wen Liu
Dong-Er Zhang
Linheng Li
Gen-Sheng Feng
University of California, San Diego · USSanford Burnham Prebys Medical Discovery Institute · USStowers Institute for Medical Research · US

Funding

Tyrosine Dephosphorylation and Blood Cell DevelopmentR01HL096125 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL096125NHLBI NIH HHS R01HL096125
6 · The paper itself

Abstract

The stem cell factor (SCF)/Kit system has served as a classic model in deciphering molecular signaling events in the hematopoietic compartment, and Kit expression is a most critical marker for hematopoietic stem cells (HSCs) and progenitors. However, it remains to be elucidated how Kit expression is regulated in HSCs. Herein we report that a cytoplasmic tyrosine phosphatase Shp2, acting downstream of Kit and other RTKs, promotes Kit gene expression, constituting a Kit-Shp2-Kit signaling axis. Inducible ablation of PTPN11/Shp2 resulted in severe cytopenia in BM, spleen, and peripheral blood in mice. Shp2 removal suppressed the functional pool of HSCs/progenitors, and Shp2-deficient HSCs failed to reconstitute lethally irradiated recipients because of defects in homing, self-renewal, and survival. We show that Shp2 regulates coordinately multiple signals involving up-regulation of Kit expression via Gata2. Therefore, this study reveals a critical role of Shp2 in maintenance of a functional HSC/progenitor pool in adult mammals, at least in part through a kinase-phosphatase-kinase cascade.

Indexed as

Adult Stem CellsAnemia, AplasticAnimalsApoptosisBase SequenceBone Marrow DiseasesBone Marrow Failure DisordersBone Marrow TransplantationCell ProliferationDown-RegulationEmbryonic Stem CellsFeedback, PhysiologicalGATA2 Transcription FactorHematopoiesisHematopoietic Stem CellsHemoglobinuria, ParoxysmalGata2 protein, mouseGATA2 Transcription FactorProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins c-kitPtpn11 protein, mouseRNA, Small Interfering

Identifiers

PMID21450902
PMCPMC3109710
OpenAlexW1983806724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.